| 000 | 01047 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518000044.0 | ||
| 264 | 0 | _c20190528 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1744-6880 | ||
| 024 | 7 |
_a10.1097/FPC.0000000000000351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuddart, Rachel | |
| 245 | 0 | 0 |
_aPharmGKB summary: oxycodone pathway, pharmacokinetics. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _c10 2018 |
||
| 300 |
_a230-237 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolic Networks and Pathways _xdrug effects |
| 650 | 0 | 4 |
_aOxycodone _xmetabolism |
| 650 | 0 | 4 | _aPharmacogenetics |
| 700 | 1 | _aClarke, Melissa | |
| 700 | 1 | _aAltman, Russ B | |
| 700 | 1 | _aKlein, Teri E | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 28 _gno. 10 _gp. 230-237 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0000000000000351 _zAvailable from publisher's website |
| 999 |
_c28842737 _d28842737 |
||